﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Avicenna Journal of Medical Biochemistry</JournalTitle>
      <Issn>2345-4113</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>10</Month>
        <DAY>31</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Assessment of Zinc Administration on Metabolic Profile, Oxidative Stress, and Gene Expression in Patients Undergoing Methadone Maintenance Treatment: A Randomized, Double-Blind, Placebo-Controlled Trial</ArticleTitle>
    <FirstPage>1</FirstPage>
    <LastPage>9</LastPage>
    <ELocationID EIdType="doi">10.34172/ajmb.2589</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Ghaseminejad</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-5070-2612</Identifier>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Ghaderi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9193-6039</Identifier>
      </Author>
      <Author>
        <FirstName>Somayyeh</FirstName>
        <LastName>Ghotloo</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-4772-6365</Identifier>
      </Author>
      <Author>
        <FirstName>Hadis</FirstName>
        <LastName>Aboutalebian</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0006-1420-1649</Identifier>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Akbari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7486-8580</Identifier>
      </Author>
      <Author>
        <FirstName>Esmat</FirstName>
        <LastName>Aghadavood</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9456-9238</Identifier>
      </Author>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Banafshe</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4450-8861</Identifier>
      </Author>
      <Author>
        <FirstName>Nejat</FirstName>
        <LastName>Kheiripour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0684-7125</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ajmb.2589</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>01</Month>
        <Day>19</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>04</Month>
        <Day>22</Day>
      </PubDate>
    </History>
    <Abstract>Background: Methadone maintenance treatment (MMT) causes important clinical problems, such as oxidative stress (OS) and inflammation. Zinc (Zn) has antioxidant and anti-inflammatory effects and regulates gene expression. Objectives: This study investigated the effects of Zn administration on the metabolic, OS, and expression of nuclear factor erythroid 2-related factor 2 (Nrf2), nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ), and interleukin 10 genes in heroin patients undergoing MMT. Methods: This clinical trial was conducted on 45 patients under MMT who received 30 mg/d of Zn (n=23) or placebo (n=22). Fasting blood samples were collected at baseline and 12 weeks after the intervention to quantify metabolic parameters, OS, and gene expression. Results: Zn levels were significantly elevated in the intervention group compared to the placebo group. Further, consuming Zn could significantly improve high-density lipoprotein levels, insulin, homeostasis model assessment-estimated insulin resistance, and OS. Anxiety significantly decreased after 12 weeks of intervention. Finally, Zn up-regulated Nrf2 gene expression in patients under MMT. Conclusion: The results indicated that Zn administration could improve metabolic factors and gene expression in patients undergoing MMT  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Addiction</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Opioid</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">PPARγ</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Nrf2</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Lipid profile</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>